Novocardio
Latest round
- Angel
Last raised
- Feb 2018
Total raised
- Undisclosed
Investors
- 1
About Novocardio
Established in 2016 and based in Beijing, China, Novocardio is a biotechnology developer of gene sequencing, providing genetic testing services for cardiovascular diseases. The company's main business is to provide clinical testing and scientific research collaboration services for cardiovascular diseases. Its business is applied in the fields of medical treatment, microbiology, animal and plant research and modern agricultural breeding. The company’s revenue is generated by providing cardiovascular disease clinical testing and scientific research collaboration services.
Who invested in Novocardio
1 investor across 1 round
See all investors in Novocardio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Feb 8, 2018
Amount
Undisclosed
Investors
Questions about Novocardio
Who invested in Novocardio?
Novocardio has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Novocardio raised?
Novocardio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Novocardio last raise money?
Novocardio's most recent round on record is a Angel, in Feb 2018.
What does Novocardio do?
Established in 2016 and based in Beijing, China, Novocardio is a biotechnology developer of gene sequencing, providing genetic testing services for cardiovascular diseases.
Where is Novocardio headquartered?
Novocardio is headquartered in Beijing, China.
Which VCs invest in companies like Novocardio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Novocardio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like Novocardio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.